Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
about
An experimental approach to study the function of mitochondria in cardiomyopathyAssessment of cardiac sarcoidosis with advanced imaging modalitiesA Drosophila model of high sugar diet-induced cardiomyopathy'Browning' the cardiac and peri-vascular adipose tissues to modulate cardiovascular riskIn obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidationReduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant miceProteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart.Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation.Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trialAssessment of myocardial triglyceride oxidation with PET and 11C-palmitateCarnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats.Pathway of free fatty acid oxidation in human subjects. Implications for tracer studies.Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.Free fatty acid uptake in humans with CD36 deficiency.Partial fatty acid oxidation inhibitors for stable angina.Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.Modulating fatty acid oxidation in heart failure.Chronic cocaine use and its association with myocardial steatosis evaluated by 1H magnetic resonance spectroscopy in African AmericansG protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experimentsMetabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies.Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feedingMitochondrial energy metabolism in heart failure: a question of balance.Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic miceAbnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated CardiomyopathyThermoneutrality modifies the impact of hypoxia on lipid metabolismThe Failing Heart Relies on Ketone Bodies as a Fuel.The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvementMitochondrial protein hyperacetylation in the failing heartGlucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs.Fat depots, free fatty acids, and dyslipidemiaInsulin resistance: metabolic mechanisms and consequences in the heart.Physical inactivity differentially alters dietary oleate and palmitate trafficking.Myocardial FFA metabolism during rest and atrial pacing in humans
P2860
Q26801342-BFE76B28-ED6E-4496-B431-B37D529DE291Q27024252-40D1C965-C02D-4819-9F94-2D0EBE426D44Q27325739-5839764F-6F6D-4877-A22C-B6FE944AF66DQ28066261-9B86212F-0181-4CE7-BFB0-385AE91CC181Q28386200-79BD6910-A61E-481A-B81A-FA9136B72F84Q28584714-74118954-1597-485A-8819-BA4F2D03A4CEQ30915732-7BBA5C01-A6B7-4319-BF71-B4FA665FE60EQ33434386-2113639A-BE3A-4D3A-A845-7044B510702EQ33742608-A0720BCF-5B74-4314-87F4-E8EDE633DC84Q33789186-FF5B06F5-CAD2-4413-9BF4-BE4D4977B007Q33894446-E1F6C2FC-1709-4EE0-9FC7-54F655DB5AA4Q33922106-294F394A-7F37-400B-A89C-64A5198C7A2CQ33991754-32130B7A-5267-4879-8AFF-9A5580C001DEQ34170254-DF62BA5E-8F02-4C5B-9C28-5BA58B90A035Q34195531-EA6C8CAA-60BB-4D9B-8276-5326A664CC1AQ34352004-71BDEF9E-0C18-4E25-873F-50127C42B170Q34361776-8D6C50E8-7959-4204-8243-C9C426B5F3D2Q34393384-E434F9C2-9098-4B8A-B829-544DE90E4E10Q34628656-7EF0B10D-8C34-4C92-97E3-DB530390BEEDQ34700405-AB6F2831-A47D-43AC-B86C-075BD7B29BA5Q34808505-733067FF-2814-4B3C-8BE8-648592AEC154Q35027864-BE90BF57-3FE2-4694-AEC4-283E08903DD5Q35041039-6963B5AC-15DF-4017-BE7C-01EA17AFA414Q35594738-89AB912F-AE0D-4DF2-AD53-6B6AA2BF91C3Q35667039-95CD0C63-E431-4E3D-AED0-F4D253DADF2EQ35892161-21EC7FDE-BC12-411D-83DD-4596ACCEF5F5Q36024334-E3E93A5B-72F9-4741-A0B3-69FD7FAD91CDQ36070074-8429D13D-B0A5-44DD-8B87-773E7B2C841FQ36281111-7AF81703-EAF1-41CF-A6B3-8F4B978E3B82Q36410776-8DEEEB47-E6D7-4727-BE3F-2DD0AA9A7719Q36424416-BB3F1182-7F07-4696-82D7-1F49C91ED233Q36593076-46033EAF-487E-4077-9062-1761702C8125Q36614537-DD6023F2-1937-4806-98B5-43AFBD6A2809Q36670175-B5D1F4C8-FFAA-42B4-9AC5-D0D8582FB69BQ36697686-E796C623-44DA-427C-B335-DF2DCE5F7597Q36787377-4ACCECA8-B6B5-4D4C-A609-C99EEB1C6EAFQ36792405-DDC46ED7-EC5C-4F08-B306-265E708A760DQ36821424-55627DE1-5B4A-47AE-B94B-A9BA554580A3Q37066890-98F7B8F6-97DC-49DD-A9B1-DAD20B6B7D1DQ37102859-DFD39B8F-3A75-4758-B68D-AB34952D7813
P2860
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@ast
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@en
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@nl
type
label
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@ast
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@en
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@nl
prefLabel
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@ast
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@en
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@nl
P2093
P2860
P356
P1476
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
@en
P2093
P2860
P304
P356
10.1172/JCI112820
P407
P577
1987-02-01T00:00:00Z